Physician Profile

Saint Luke’s Care Member

Physician Profile

Stanley P Fisher, MD

Neurology

Education

Medical School
Drexel University (Formerly-Hahnemann Univ) School of Medicine, Philadelphia, PA
Internship
Transitional, Lankenau Medical Center, Wynnewood, PA
Residency
Neurology, University of Texas at Houston, Houston, TX
Fellowship
Movement Disorders, University of Texas at Houston, Houston, TX

Board Certifications

  • American Board of Psychiatry & Neurology [Neurology]

Clinical Interests

  • Parkinson's disease
  • tremor
  • gait disorders
  • normal pressure hydrocephalus
  • spasticity
  • dystonia

Biography

Stanley P. Fisher, M.D., is co-director of Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI) in Kansas City, Mo. He joined Saint Luke’s in March 2015 to help advance the neuroscience institute’s clinical practice and research in close collaboration with the University of Missouri–Kansas City School of Medicine. 

At UMKC, Dr. Fisher is associate professor in the Department of Neurology and a secondary appointment in the Department of Psychiatry. He was also appointed as Edward T. Matheny, JR/Missouri Endowed Chair in Neurosciences with the mandate to define the future of neuroscience through innovation, research, and state-of-the-art clinical care as well as the management of an academic program of neurosciences. 

Before Saint Luke’s, Dr. Fisher was with the Houston Methodist Neurological Institute (HMNI) for nearly a decade. He was founder and co-director of the Movement Disorders and Neurorehabilitation Center at HMNI, elected deputy vice chair of neurology at the Houston Methodist Hospital, associate professor of clinical neurology at Weill Cornell Medical College, and is a fellow of the American Neurological Association. He was also appointed as an associate member of Houston Methodist Research Institute in recognition of his achievement in clinical and translational research.

Under his leadership, the HMNI’s Movement Disorders and Neurorehabilitation Center has become a center of excellence for deep brain stimulation, intrathecal baclofen, and botulinum toxin therapy–with frequent on-site training for neurologists and physiatrists from all over the country. Dr. Fisher was actively involved in training students, residents, and fellows during his tenure and served as a co-chair of the HMNI’s Annual Advances in Neurology seminar for eight years, an event that attracted neuroscientists from every state of the union.

Dr. Fisher was a robotic engineer before returning to Temple University, where he graduated summa cum laude with a B.A. in biology and cognitive neuroscience. During his college years, Dr. Fisher was a well-known personal and fitness trainer in Philadelphia.

He graduated from the MCP-Hahnemann School of Medicine in Philadelphia and completed his internship before moving to Texas.

After he completed his residency in neurology and fellowship in movement disorders at the University of Texas–Houston, Dr. Fisher combined his skills as a robotic engineer, fitness trainer, and neurologist to do research on robotically-assisted technology for neurological rehabilitation. He became a nationally recognized expert in the field of neuromodulation, utilizing implantable devices for the treatment of Parkinson disease, tremor, dystonia, spasticity due to stroke, multiple sclerosis, traumatic brain, and spinal cord injury. For eight years, he has served as founder and program director for Neurological Rehabilitation at the HealthSouth Center for Neurological Research and Recovery in Houston, which included four acute rehabilitation hospitals throughout the area.

For the last 2 years, he has served as a program director for Neurological Rehabilitation for Reliant Hospitals in the Houston metro area.

Dr. Fisher was involved in clinical research related to psychosis and emotional lability in patients with neurodegenerative disorders. For the last three years, he served as medical director for four Silverado Memory Care communities in Houston.

During his tenure in Houston, Dr. Fisher conducted sponsored and investigator-initiated trials in the field of Parkinson’s disease, stroke, spinal cord injury, and Alzheimer’s disease.

Dr. Fisher has been invited to lecture nationally and internationally on the topics of Parkinson disease, spasticity, and the use of implantable and robotically-assisted devices for the treatment of the wide variety of neurological diseases.

Dr. Fisher has a special interest in the field of targeted drug delivery and chaired an annual conference on the role of targeted drug delivery in the treatment of pain and neurological diseases. Dr. Fisher was the first neurologist in the United States to implant the Medstream Intrathecal Drug Delivery System and was a main investigator for the device.

Dr. Fisher also was adjunct professor at the Department of Health and Human Performance at the University of Houston and was actively involved in the research on motor control at the Center for Neuromotor and Biomechanics Research at the National Center for Human Performance. He mentored many graduate, PhD, and post-doctoral students in his lab and taught an annual graduate seminar on neurorehabilitation at the University of Houston.

During his tenure in Houston, Dr. Fisher has served on the board of multiple professional and charitable organizations, including Houston Neurological Society, Texas Neurological Society (TNS), and Houston Area Parkinson Society. He also served as a president of Harris County Neurological Society from 2008 to 2009 and as a president of Houston Neurological Society from 2013 to 2015. Dr. Fisher was program director for the TNS in 2013 and continued to chair residents’ annual poster competition for many years. As the regional leader, he fostered an unprecedented collaboration between the three academic institutions in the Texas Medical Center that encouraged mutual research, education, as well as resident and junior faculty development.

Dr. Fisher very frequently spoke to patient support groups around the country to educate and encourage people with chronic neurodegenerative diseases.

Dr. Fisher was actively involved in the academic life of the Houston Methodist Hospital and was one of the founding members of the continuing medical education (CME) committee where he served for six years. He was also chair of the care management performance improvement committee (CMPI) for the neurology service line during his term.

Accepted Insurances

  • Aetna Choice POS II
  • Aetna Choice POS II Aexcel Local
  • Aetna Choice POS II Local
  • Aetna Elect Choice
  • Aetna Federal Employees Health Benefit Plan
  • Aetna HMO
  • Aetna HMO Local
  • Aetna Mail Handlers Benefit Plan
  • Aetna Managed Choice
  • Aetna MDOT & Missouri State Highway Patrol
  • Aetna Medicare
  • Aetna Missouri Preferred
  • Aetna MU myChoice Health Program
  • Aetna Open Choice PPO
  • Aetna Select
  • Aetna Select Local
  • Aetna Signature Administrators (ASA)
  • Aetna Workers Comp
  • BCBS of Kansas (call provider)
  • BCBS of Kansas City (PPO)
  • BCBS of Kansas City Freedom Network
  • BCBS of Kansas City Freedom Network Select
  • BCBS of Kansas City Preferred Care
  • BCBS of Kansas City Preferred Care Blue
  • BCBS of Kansas City Traditional
  • Beech Street (PPO)
  • Century Health Solutions (PPO)
  • Cigna (HMO)
  • Cigna (Open Access)
  • Cigna (PPO)
  • Cigna HealthSpring (HMO Medicare Advantage)
  • CompResults (WC)
  • Coventry Advantra Freedom (PPO)
  • Coventry Health and Life Insurance Company
  • Coventry Health Care
  • Coventry Medicare Advantra (PPO)
  • Golden Rule
  • Great West HealthCare (POS)
  • Great West HealthCare (PPO)
  • Great West HealthCare One Health Plan
  • Great West HealthCare One Health Plan/Gen AM
  • Health Choice of Northwest Missouri (PPO)
  • Healthcare USA-MC+ (Aetna Better Health)
  • HealthLink (HMO)
  • HealthLink (PPO) through Freedom Network
  • Home State Health Plan (Missouri practices)
  • Humana (PPOx)
  • Humana Choice Care (PPO)
  • Humana Choice PPO (Medicare Advantage PPO)
  • Humana Gold Choice Medicare Advantage PFFS
  • Humana Gold Plus (HMO)
  • Humana Gold Plus HMO SNP
  • Humana SmartExpress PPO
  • Humana SmartNet PPO
  • Humana SmartSuite PPO
  • HumanaOne
  • Integrated Health Plan
  • Kansas Medicaid
  • Medicare
  • Missouri Care (Missouri practices only)
  • Missouri Medicaid
  • MultiPlan/PCHS (PPO)
  • Occupational Health Management (WC)
  • OHARA Managed Care (WC)
  • ProviDRs Care Network (formerly WPPA)
  • Pyramid Life (Medicare Advantage PPO)
  • Railroad Medicare
  • Sunflower State Health Plan (Kansas practices)
  • TRICARE
  • Triwest Veterans Affairs Patient Centered Community Care
  • United Healthcare Choice
  • United Healthcare Choice Plus
  • United Healthcare Community Plan
  • United Healthcare Definity Health Reimbursement Account
  • United Healthcare Definity Health Savings Account
  • United Healthcare Golden Rule HMO
  • United Healthcare Indemnity
  • United Healthcare Managed Indemnity
  • United Healthcare Options PPO
  • United Healthcare Select
  • United Healthcare Select Plus
  • UnitedHealthcare Evercare DH
  • UnitedHealthcare Evercare DH-POS
  • UnitedHealthcare Evercare DP
  • UnitedHealthcare Evercare RDP
  • UnitedHealthcare Medicare Choice
  • UnitedHealthcare Medicare Choice Essential
  • UnitedHealthcare Medicare Complete
  • UnitedHealthcare Medicare Complete Essential
  • UnitedHealthcare Medicare Complete Plus
  • UnitedHealthcare Medicare DH
  • UnitedHealthcare Medicare Plus Essential
  • US Department of Labor

Publications

Peer Reviewed Articles

Lee B-C, Thrasher TA, Fisher S, Layne CS. The effects of different sensory augmentation on weight-shifting balance exercises in Parkinson’s disease and age-matched healthy elderly individuals. [April 2015: Submitted to JNER]

Fisher, S.  Primer on Diagnoses and treatment of Symptomatic Neurogenic Orthostatic Hypotention.

East European Journal of Parkinson’s Disease and Movement Disorders. – 2015. – Vol. 1, No. 1

Thrasher TA, Fisher S. Changes in Muscle Coordination Following Robot-assisted Gait Training in Hemiparetic Stroke. Journal of Novel Physiotherapies; Volume 4, Issue 4, June 30, 2014.

Thrasher TA, Fisher S. Societal Costs of Intrathecal Drug Delivery Systems – An Administrative Analysis Based on Patient Claims. Neuromodulation 2013; 16:261-265.

Thrasher TA, Ward JS, Fisher S. Strength and endurance adaptations to functional electrical stimulation leg cycle ergometry in SCI. NeuroRehabilitation 2013; 33(1):133-8.

Thrasher TA, Ward JS, Fisher S. Classification of rhythmic locomotor patterns in electromyographic signals using fuzzy sets. Journal of Neuroengineering and Rehabilitation, November 2011.

Stanley Fisher, MD, Leah Lucas, T. Adam Thrasher, PhD.

Robot-assisted gait training for patients with hemiparesis due to stroke Topics in Stroke Rehabilitation.  Topics in Stroke rehabilitation, 2011;18(3):269-276

Mya Schiess, MD, Irene Oh, MD, Erin F. Stimming, MD,  Joseph Lucke, PhD, Fernando Acosta, MD, Stanley Fisher, MD, Richard Simpson, MD, PHD. Prospective 12-Month Study of Intrathecal Baclofen for Poststroke Spastic Upper and Lower Extremity Motor Control and Functional Improvement. Neuromodulation: Technology at the Neural Interface 2011;14:38-45.

Song, J.K., Fisher, S., Seifert, T.D., Cacayorin, E.D., Alexandrov, A.V., Malkoff, M.D., Grotta, J.C., Campbell, M.S.  Postpartum Cerebral Angiopathy:  Atypical Features and Treatment with Intracranial Balloon Angioplasty.  Neuroradiology. Dec 2004.

Song, J.K., Cacayorin, E.D., Campbell, M., Fisher, S., Malkoff, M.D., Alexandrov, A.V., Grotta, J.C.  Intracranial Balloon Angioplasty of Acute Terminal Internal Carotid Artery Occlusions.  AJNR. 23:1308-1312, Sep 2002.
 

Abstracts

Assessment of Guidance Modality on weight-shifting balance exercises in individuals with PD

2015 ISPGR World Congress, Seville, Spain, 6/28-7/2/2015

Tactile Cueing Improves Motor Performance and Motor-Cognitive Integration in Parkinson's Disease; AAN meeting 2014.

Alterations In Muscle Coordination Following Robot-Assisted Gait Training In Hemiparetic Stroke: A Case Series; AAN meeting 2014.

The muscular endurance and strength benefits of 13 weeks of Functional Electrical Stimulation cycling after spinal cord injury; North American Neuromodulation Society Meeting, Dec 2009.

The muscular endurance and strength benefits of 13 weeks of Functional Electrical Stimulation cycling after spinal cord injury.  International Journal of Exercise Science. Oct 2009.

Use of Autoambulator for Mobility Improvement in Patients with Central Nervous System (CNS) Injury or Disease. Neurorehabilitation and Neural Repair. 2008; 22: 556.

Functional Motor Improvement in Stroke Related Spastic Hemiparesis after Intrathecal Baclofen Pump Therapy. Neurology. Volume 66(2), Mar 2006.

Intrathecal Baclofen Pump Therapy Improves Functional Motor Control and Quality of Like in Spastic Hemiplegia after Stroke; 8th Int’l Congress of Parkinson’s Disease and Movement Disorders, June 14-17, 2004; Rome, Italy.

 

On Staff At

  • Saint Luke's Hospital of Kansas City
  • Saint Luke's North Hospital–Barry Road
  • Saint Luke's North Hospital–Smithville